BTT-266 is an antagonist for calcium channel , through suppression of the Ca V α 1-AID -Ca V β 3 interaction, with a K i of 1.4 μM. BTT-266 modulates the activation of voltage-dependent Ca V 2.2. BTT-266 exhibits analgesic efficacy against neuropathic pain in rats model.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Hypertension | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Calcium Channel
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.